Carbamazepine

Product NDC
0615-8545
11-digit product format
006158545
Labeler code
0615
Product ID
0615-8545_bdd761fd-0c62-4cfb-8155-71cd634e1c86
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Carbamazepine
Dosage form
TABLET
Route
ORAL
Labeler
NCS HealthCare of KY, LLC dba Vangard Labs
Application
ANDA074649
Marketing category
ANDA
Marketing start
1996-10-03
Substance
CARBAMAZEPINE
Active strength
200 mg/1
Pharmacologic classes
Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Related Records

Related UNII Ingredients

UNIIPreferred termRegistry numberMatched term
33CM23913MCARBAMAZEPINE298-46-4CARBAMAZEPINE

Packages

Package NDC11-digit formatDescriptionUnitsMarketing startSampleExclude flagStatus
0615-8545-390061585453930 TABLET in 1 BLISTER PACK (0615-8545-39) 30 tablet2024-10-09NoNoHistorical

Related DailyMed Labels

TitleManufacturerEffective dateTypeVersion
CarbamazepineNCS HealthCare of KY, LLC dba Vangard Labs2024-10-10HUMAN PRESCRIPTION DRUG LABEL1